Aviance Capital Partners, LLC
Source: SEC Form 13F · as of Mar 2026Aviance Capital Partners, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $83.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$83.0M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 146,965 | $32.0M |
| AMGNAMGEN INC | 36,514 | $12.8M |
| JNJJOHNSON & JOHNSON | 33,621 | $8.2M |
| MRKMerck & Co., Inc. | 41,782 | $5.0M |
| PFEPFIZER INC | 165,588 | $4.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 16,921 | $4.6M |
| ZTSZoetis Inc. | 27,576 | $3.3M |
| ABTABBOTT LABORATORIES | 24,106 | $2.5M |
| LLYELI LILLY & Co | 2,378 | $2.2M |
| BMYBRISTOL MYERS SQUIBB CO | 33,804 | $2.1M |
| JAZZJazz Pharmaceuticals plc | 6,879 | $1.3M |
| PMPhilip Morris International Inc | 6,488 | $1.1M |
| MCKMcKesson Corporation | 830 | $718K |
| GILDGILEAD SCIENCES, INC. | 4,784 | $667K |
| OGNOrganon & Co. | 105,723 | $633K |
| IDXXIDEXX LABORATORIES INC /DE | 750 | $421K |
| NVONovo Nordisk A/S | 10,086 | $371K |
| DVADaVita Inc. | 2,000 | $307K |
| GMOptec International, Inc. | 2,805 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.